key: cord-0958230-brobg2eu
authors: Tong, Jianbo; Zhang, Xing; Luo, Ding; Bian, Shuai
title: Molecular design, molecular docking and ADMET study of cyclic sulfonamide derivatives as SARS-CoV-2 inhibitors
date: 2021-09-29
journal: Chinese Journal of Analytical Chemistry
DOI: 10.1016/j.cjac.2021.09.006
sha: 77f907ecaa7ae2d2f92c37bbaca08dca7eb3eda7
doc_id: 958230
cord_uid: brobg2eu

Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) continues to spread globally, with more than 172 million confirmed cases and 3.57 million deaths. Cyclic sulfonamide derivative was identified as a successful compound and showed anti-SARS-CoV-2 activity. In this study, the structure and activity relationships of 35 cyclic sulfonamide compound inhibitors were investigated by using three-dimensional quantitative structure-activity relationship (3D-QSAR) and holographic quantitative structure-activity relationship (HQSAR).Two models with good statistical parameters and reliable predictive ability were obtained from the same training set, including Topomer CoMFA ( q 2 = 0.623, r 2 = 0.938, r p r e d 2 = 0.893) model and HQSAR ( q 2 = 0.704, r 2 = 0.958, r p r e d 2 = 0.779 ) model, the established models not only have good stability, but also show good external prediction ability for the test set. The contour and color code maps of the models provide a lot of useful information for determining the structural requirements affecting the activity; this information paved the way for the design of four novel cyclic sulfonamide compounds, and predicted their pIC50 values. We explore the interaction between the newly designed molecule and SARS-CoV-2 3CLpro by molecular docking. The docking results showed that GLU166, GLN192, ALA194, and VAL186 may be the potential active residues of the SARS-CoV-2 inhibitor evaluated in this study. Finally, the oral bioavailability and toxicity of the newly designed cyclic sulfonamide compounds were evaluated and the results showed that the four newly designed cyclic sulfonamide compounds have major ADMET properties and can be used as reliable inhibitors against COVID-19. These results may provide useful insights for the design of effective SARS-CoV-2 inhibitors.

protein shell and prevents the increase of viral load in the host cell, which is critical for the viral life cycle, making it an attractive target for anti-SARS-CoV-2 inhibitors [6] . Therefore, 3CLPro is considered a prime target for the treatment of SARS-CoV-2 infection.

As an important class of compounds, sulfonamides have a wide range of applications in medicine and pesticides. There are many sulfonamides in the market for the treatment of diseases with different properties, because they can identify various protein targets. Sulfonamide derivatives are an important part of many biologically active compounds and drug molecules, such as anti-bacterial [7] , anti-cancer [8] , anti-inflammatory [9] , anti-tumor [10] and anti-malaria [11] . cyclic sulfonamide derivatives are known to have various pharmacological activities, such as analgesia [12] , anti-inflammatory [13] and anti-diabetic [14] . Recently, there has been much increased interest in cyclic sulfonamide derivatives as they show potential inhibition of SARS CoV-2 3CLpro, and in this study we focused on cyclic sulfonamide derivatives as inhibitors of SARS-CoV-2.

The establishment of a quantitative structure-activity relationship (QSAR) model can guide the modification of compound structures, design new and more active compounds, and predict their activity. Commonly used QSAR models include 2D-QSAR and 3D-QSAR [15] . 3D-QSAR correlates biological properties with structural descriptors and is used to predict the activity value of non-synthetic molecules, which is an important method for molecular modeling. The techniques most commonly used in 3D-QSAR are comparative molecular field analysis (CoMFA) and comparative molecular similarity index analysis (CoMSIA) [16] . However, CoMFA has many limitations, which can be limited if the molecular structure is not three-dimensional in the database. Topomer comparative molecular field analysis (Topomer CoMFA) is the second-generation CoMFA method that overcomes many limitations of CoMFA, and can predict the bioactivity of compounds in just a few minutes, making it more repeatable. 2D-QSAR is a method to quantitatively describe the relationship between the physicochemical properties and other measurable properties of a compound structure and its activity through a linear model or a nonlinear model [17] . HQSAR is a relatively new 2D-QSAR method, which realizes the need of molecular arrangement and conformation specification by converting the chemical representation of the molecule into its corresponding molecular hologram.

In this study, 35 SARS-CoV-2 inhibitors were studied using two methods, 2D-HQSAR and 3D-Topomer CoMFA, and key structural factors affecting the inhibitory activity were identified. 

Bioactivity and molecular structure of a series of cyclic sulfonamide compounds as inhibitors of SARS-CoV-2 was obtained by literature search and used as a data set for molecular modeling [18] . The chemical structure and activity data were shown in Table S1 . Among the 35 inhibitors, the IC 50 values ranged from 0.88 to 25 M. Equation (1) was used to convert them into pIC 50 values to provide a larger value as the dependent variable for the model construction, and the pIC 50 values were obtained in the range of 4.60 ~ 6.06. Fig.2 shows the distribution of pIC 50 values for all inhibitors, indicating that the diversity of activities in the data set is sufficient to construct a stable QSAR model. According to the pIC 50 value and molecular structure, 35 inhibitors were divided into two groups: 23 compounds were assigned to the training set for model establishment, and 12 compounds were allocated to the test set for model verification. 

The two-dimensional structure of the SARS-CoV-2 inhibitor was drawn in Chem Draw Ultra v8.0.3 (PerkinElmer, Waltham, MA, USA) and converted into a 3D structure using SYBYL-X 2.0 (Tripos Software, Saint Louis, MO, USA) [19] . Tripos force field and Powell conjugate gradient algorithm with convergence criterion of 0.005 kcal/mol Å were adopted, and the maximum iteration set was set as 1000 [20] . The Gasteiger-Hückel method was used to calculate partial atomic charges of compounds under electrostatic interaction, and the remaining parameters were Topomer CoMFA default value to obtain the low energy conformation of each molecule (Pharmacodynamic conformation).

Structure alignment is one of the most important input variables in 3D-QSAR analysis, and the prediction accuracy of the model depends on the contour map of molecular structure comparison.

Topomer CoMFA can simultaneously describe the changes of the electrostatic field and the steric field around the molecule, reveal the molecular structure information that affects the biological activity more comprehensively, and determine the group properties that affect the molecular activity. In this experiment, the molecule No. 33 with the highest activity value in the training set was used as the cutting template. The splitting mode of R group is very important for the generation of Topomer CoMFA model. Therefore, we compared two different split modes for modeling research (Fig. 3) . The remaining few molecules that cannot be automatically recognized will be manually broken until all the molecules have been cut, and the resulting structural fragments will be used for subsequent analysis of model results and virtual screening research. Fig. 3 . Cutting method of model 1 (a) and model 2(b). Blue represents the R 1 group, red represents the R 2 group, yellow represents the R 3 group, and green represents the common skeleton

The contribution map obtained by the HQSAR method can clearly show where the inhibitor molecule needs to be optimized; it can get the advantages and disadvantages of the atom or group on the molecular activity, and find a suitable replacement group for molecular design. Therefore, combining the Topomer CoMFA model with the HQSAR model and applying it to molecular modification can not only accurately locate the active site, but also determine the groups and atoms that affect the corresponding properties of the molecular activity.

HQSAR is a new QSAR technology which is based on fragments and has high predictive ability.

There is no need to determine the 3D structure, molecular comparison and assumed conformation [21] , which has irreplaceable advantages in molecular design. All possible molecular fragments (such as linearity, branching, overlap, hybridization, and chirality) can be encoded in molecular holograms.

Each compound is divided into structural fragments defined by fragment discrimination (FD) parameters: atomic number (A) can distinguish atom types, bond type (B) can distinguish chemical bonds formed between atoms, and atomic connections (C) can distinguish the hybridization state of the atoms inside the fragment, hydrogen (H), chirality (Ch) can distinguish the chirality of the atom in the fragment and the stereochemical information of the chemical bond, and the donor/acceptor (DA) distinguishes the hydrogen bond donor or acceptor of the fragment. The cyclic redundancy check (CRC) algorithm is used to assign a specific positive integer to each segment, ranging from 0 to 231. Each of these integers was in correspondence with a bin in an integer array of hologram length (HL, ranging from 53 to 401) and the bin occupancies of the molecular hologram are structural descriptors [22] . In the HQSAR method, there is a partial least squares (PLS) relationship between these descriptors and attribute values. Many parameters related to hologram generation, such as HL, fragment size (FS) and FD, will affect the quality of the HQSAR model [23] .

The fragment parameters determine the topological information mapped in the molecular hologram, and the model can be optimized by changing the fragment parameters and fragment size. In the process of building the HQSAR model, we selected all 12 holographic lengths (HL) (53, 59, 61, 71, 83, 97, 151, 199, 257, 307, 353 and 401), the default FS (4-7), and different combinations of FD (atoms, bonds, chirality, connection, hydrogen bond donor and hydrogen bond acceptor) to generate the initial model. 25 HQSAR models were analyzed to study the influence of different FD combinations on the model, so as to preliminarily screen out the better model. Then, on the basis of the selected the better model, different fragments lengths were selected to analyze the influence of different fragments lengths on the HQSAR analysis results, so as to obtain the optimal HQSAR model.

In 3D-QSAR research, the PLS method [24] is an extension of multiple regression analysis to analyze the relationship between quantitative descriptors and biological activity in the model. The established model descriptors (electrostatic field and stereo field parameters) were used as independent variables, and pIC 50 was used as the dependent variable for regression analysis. The leave-one-out method ( ) cross-validation is one of the simplest methods for internal model verification [25] .

method is used for model fitting, and the method is used to cross-validate and evaluate the predictive ability of the model's internal verification, and the optimal group score ( ) is determined.

At the same time, the cross-validation correlation coefficient ( 2 ), the standard error of estimation ( ), the non-cross-validation correlation coefficient ( 2 ) and the Fischer ratio value ( ) are calculated to verify the stability of the constructed model. Among them, 2 and are automatically generated by the system. The larger the 2 and values, the smaller the value, which proves that the model's fitting ability is stronger, 2 : <0 (the model predictive ability is poor), 0.4 ~ 0.5 (the model can be considered), ˃ 0.5 (a statistically significant prediction model); high 2 and 2 ( 2 ＞0.5 , 2 ＞0.6) value can prove that the established 3D-QSAR model and HQSAR model have high predictive ability [26] . The 2 ， 2 ， ，and are calculated for the data set as equations (2)-(5):

Where is the experimental value of biological activity; is the simulated fitting value of biological activity; is the number of samples; is the number of parameters used in modeling;

is the predicted activity of the test set compounds; is the calculated average activity of the training set compounds.

Studies have shown that there is no correlation between internal prediction ability ( 2 ) and external prediction ability ( 2 ). The 2 obtained by the method cannot be used to evaluate the external predictive ability of the model [27] . The established model has good internal prediction ability, but the external prediction ability may be very low, and vice versa. Therefore, the QSAR model must pass effective external validation to ensure the predictive ability of the model for external samples.

International journals such as Food Chem、Chem Eng J、Eur J Med Chem and J Chem Inf Model explicitly states that each QSAR/QSPR paper must be externally verified. The best method for external validation of the model is to use a representative and large enough test set, and the predicted value of the test set can be compared with the experimental value. The prediction correlation coefficient 2

based on the test set is calculated according to equation (6):

Where ̂: test set activity prediction value, : test set activity experimental value, : average value of training set experimental values, ̂: average value of training set prediction values.

Use test sets and classic verification standards to test the external predictive ability of the developed QSAR model: the Golbraikh-Tropsha method [29] . The usual conditions that 3D-QSAR models and HQSAR models with more reliable external verification capabilities must meet are:

Where 0 2 and 0 2 ′ are squared correlation coefficients of determination for regression lines through the origin between predicted (y) and observed (x) activities and the values of and ′ are the slopes of their models.

In addition, the rigorous and powerful statistical indicators proposed by Roy on the basis of the Golbraikh-Tropsha method are also applied: 2 .

For an acceptable model, 2 value more than 0.5 ( 2 >0.5) and 2 < 0.2 show good external predictability of the models. In addition, other kinds of methods, 1 2 , data set as equations (14)- (19):

The 3D-QSAR model of 35 cyclic sulfonamide compounds inhibitors was established by using Topomer CoMFA based on R group search technology. The molecules in the database are segmented into fragments, and the fragments are compared with the substituents in the data set, and the similarity degree of compound structure is evaluated by scoring function [31] , so as to perform virtual screening of similar structure for the molecular fragments in the database. Therefore, after the Topomer CoMFA modeling, the Topomer CoMFA module in SYBYL-X 2.0 is used for Topomer Search technology to find new molecular substituents, which can efficiently, quickly and more economically design a large number of new compounds with better activity.

In this study, by searching the compound database of ZINC (2015) [32] (a source of molecular structure fragments), the topomer technique was used to compare and find the molecular fragments with similarity. The Topomer Distance (TOPDIST) and the contribution value of substituents were integrated and the established Topomer CoMFA model scores these fragments and performs virtual screening on the cleaved fragments to obtain R 1 , R 2 and R 3 substituents with higher contribution value.

Then, SARS-CoV-2 inhibitor small molecules with better activity are obtained by splicing design.

Molecular docking is one of the most commonly used methods to study the mutual recognition process of geometric matching and energy matching in drug design. The principle of molecular docking is the "lock and key model" [33] . The lock is a macromolecular receptor with different structures, and the key is a small molecule ligand with a specific structure. When the macromolecular receptor and the small molecule ligand are complementary and matched in geometry, electrostatic interactions, hydrogen bond interactions and hydrophobic interactions will occur. Then, in the process of binding, the conformation of the small molecule ligand and its surrounding amino acid conformation gradually change, adapt to each other and induce fit.

In order to exert its inhibitory activity against SARS-CoV-2, cyclic sulfonamide compounds need to have a certain affinity with SARS-CoV-2 enzyme protein. After the two are sufficiently close to each other, they will combine with each other and interact with each other through appropriate conformational adjustment, finally forming a stable complex conformation [34] . Surflex-Dock takes polarity effect, hydrophobic effect and hydrogen bond effect into account to score the interaction between ligand and receptor, and the Total score is the dissociation constant (representing docking activity). We used SYBYL-X 2.0 (Surflex-Dock method) and Discovery Studio Visualization tool 2017

to study the molecular docking of the least active compound (2, 3, 7, 8, 25, 26, 27, 29) and the most active compound 33 with the 7JYC protein on the data set reported in the previous experimental studies to further analyze and verify the molecular structure of cyclic sulfonamide compounds [35] ; and through the comparison of the two, the reason why compound 33 has a higher inhibitory activity against SARS-CoV-2 is explained. Finally, the four newly designed inhibitor molecules were docked to understand the antiviral mechanism of the designed compound.

The three-dimensional crystal structure of protease (7JYC) comes from the PDB database (http://www.rcsb.org/). Before molecular docking, the protein receptor molecules are pretreated, the required small molecule ligands are extracted from the macromolecular complexes, and the protein's own ligands, metal ions, water molecules, and other residues and terminal residues are removed. Polar hydrogen and point charges are added to expose the binding pocket (represented by the prototype molecule) [36] . The binding pocket is filled with hydrogen bond donors, hydrogen bond acceptors and hydrophobic site molecular probes. The interaction mode of the processed prototype small molecule and protein macromolecule was shown in Fig.4(a) . The crystal structure of the protein macromolecule was extracted from the eutectic ligand, and then the crystal structure was reconnected to the eutectic ligand by molecular docking technology. The original ligand was taken as a reference, as shown in Compound 33 interacts with the active site of protein 7JYC

In addition to forming a good interaction with the target, a good drug molecule should also have good pharmacokinetic characteristics and as few toxic and side effects as possible. Molecules possessing important biological activities and suitable pharmacokinetic properties are one of the most important issues in drug design [37] . Although many molecules have important biological activities, they cannot be used clinically due to poor absorption, distribution, metabolism and excretion (ADME) parameters or toxicity. In order to meet the requirements of drug design, in recent years, ADMET prediction has become a hot research direction in the field of computer-aided drug molecular design [38] , and great progress has been made. In silicon, ADMET and toxicology screening systems can provide opportunities to predict in vivo performance. These data are very important for the availability of drugs and the design of new and more active molecules. Predetermining ADME parameters from molecular synthesis can significantly reduce failures due to inappropriate pharmacokinetic properties.

Therefore, this study used preADMET online server [39] to conduct ADMET evaluation of compounds to determine their various physicochemical properties, pharmacokinetic properties and molecular toxicological characteristics.

The template molecule (33) was specifically cut as shown in Fig.S2 and the cyclic sulfonamide derivatives inhibitor was cut into four parts. From Table S2 Table S2 , Model 1 not only has good external predictive ability, but also better retains the core skeleton of the inhibitor in the cutting method, which is conducive to the selection of R groups.

Therefore, model 1 was selected for subsequent research and molecular design.

The linear regression between the experimental and predicted values of the Topomer CoMFA model across the entire dataset is shown in Fig. 5(a) , with all samples evenly distributed around 45° line. Fig.   5 (b) shows that the predicted pIC 50 values for these compounds are highly similar to the experimental values, shows that the Topomer CoMFA model showed a satisfactory predictive ability for the low activity compounds (2, 3, 7, 8, 25, 26, 27, 29) and the highest activity compounds (33) in the whole dataset.

These results confirmed that Topomer CoMFA model had good predictive ability for cyclic sulfonamide derivatives. Therefore, the established 3D-QSAR model can be used for the screening and design of novel inhibitor molecules. 

The results of the Topomer CoMFA model are graphically interpreted using contour maps. Fig. 6 shows the calculated Topomer CoMFA electrostatic field and stereo field profile. In the stereo field map, the green part shows that increasing the volume of substituents is beneficial to the improvement in the R 2 group are distributed on both sides of the six-membered ring, and the green equipotential region is larger than the yellow equipotential region (Fig. 6(c) ), which means that increasing the volume of this group will increase the activity of the compound. Comparing the chemical structures and pIC 50 values of compound 5(R 2 =4-CF 3 -Ph, pIC 50 = 5.276), compound 1(R 2 = 3-F-Ph, pIC 50 = 4.815) and compound 2(R 2 = Ph, pIC 50 =4.602), it was found that the R 2 group was consistent with the above conclusions.

In an electrostatic field, the red area indicates that introducing a negatively charged substituent or increasing the electronegativity of the group is beneficial to the improvement of compound activity, and the blue area indicates that introducing a positively charged substituent or reducing the electronegativity of the group is beneficial to increase the activity. As shown in Fig. 6 and almost all compounds with negative R 3 groups showed better inhibitory activity. 

The performance of the HQSAR model is affected by parameters such as HL (hologram length), FD (fragment discrimination type) and FS (fragment size), and these parameters need to be refined and optimized. We initially used the default FS (4-7) and all HLs and different FD combinations to generate the model. Then select different FS to study its influence on the HQSAR analysis results to obtain the optimal HQSAR model. The HQSAR model of 37 statistical parameters is shown in Table S3 . The results show that the model generated when FD is "A + B + C + Ch" and FS is "4-7" is the best HQSAR model: 71 for hologram length and 4-7 for fragment size, showing the highest 2 (0.704) and 2 (0.958) with 6 components and the standard error of 0.091. Fig. 7(b) shows that the predicted pIC 50 values of these compounds are almost in agreement with the experimental values. Both the low activity compounds (2, 3, 7, 8, 25, 26, 27, 29) and the highest activity compounds (33) had good predictive ability, indicating that the HQSAR model had a satisfactory predictive ability. These results confirm that the HQSAR model has good predictive ability for cyclic sulfonamide derivatives. Therefore, the established HQSAR model can be used for the screening and design of novel inhibitor molecules. 

HQSAR provides color-coded diagrams as direct evidence of the contribution of individual atoms to biological activity. In this study, the selected compound 33 with the best activity was taken as the representative for the color-coded HQSAR model analysis, and its single atomic contribution is shown in Fig. S3 . Fig. 8 shows the atomic contribution diagrams (3, 7, 25, 26, 27, 29) of each series of representative molecules with the lowest activity. It is worth noting that the common skeleton color of most compounds is blue, which is a common structural fragment of all molecules and acts in the same way for all inhibitors, indicating their important role in enhancing activity.

As shown in Fig. S3 , most of the atoms of the R 1 group in the template molecule (33) are blue, indicating the importance of the R 1 group to the inhibitory activity. The -Cl atom and the -F atom at the C-3 and C-4 positions on the benzene ring are green, which are positive contributions to the activity of the cyclic sulfonamide derivative inhibitor, indicating that the introduction of the R 1 group here is beneficial to the improvement of the activity. The changes of C-2(-H)、C-3(-Cl) and C-4(-CF 3 ) on the benzene ring of R 2 group were yellow, blue and green, indicating that the contribution of these fragments or atoms to the activity of the compound increased successively, and these groups should be retained when synthesizing compounds that may have better biological activity. The F atom of the R 3 group appears green, which contributes positively to the activity improvement of the compound; the C-1 and C-5 positions on the benzene ring of the R 2 group are white, indicating that the activity of the cyclic sulfonamide inhibitor is neutral or negative. It may be substituted by a substituent that can produce a stronger inhibitory effect, which is consistent with the results of Topomer CoMFA. In Fig. 8 , almost the R 2 groups of the low-activity molecules appear white, the R 1 groups of the compounds 7, 25, 27 and 29 appear white, and the R 3 groups of the compounds 3 and 27 appear white, indicating that the inhibitor activity in these places is neutral or negative, and may be substituted by substituents that can produce stronger inhibitory effects. This also explains the reason for the low activity of these molecules. 

The external prediction correlation coefficient, Golbraaikh-Tropsha method and 2 (Roy) were used to verify the external prediction capabilities of the two models. The mathematical expressions of different statistics of HQSAR model and Tomoper CoMFA model are listed in Table S4 . It can be seen from Table S4 that indicating robust external predictive power of both models.

According to the constructed two models and related analysis results, the molecular structure was optimized using compound 33 as a template. The selected Topomer distance is close to 185, and the contribution value of each group exceeds the R group of the template molecule. As shown in Fig. S4 , we selected the R 3 group of the compound with the highest activity from the existing compounds, combined with two R 1 groups and two R 2 groups with high contribution values searched in the ZINC database, and designed four new compounds according to the permutation and combination principle.

The previously established Topomer CoMFA and HQSAR models were used to predict the activity of these new compounds. The structure of the newly designed molecule and the predicted pIC 50 value are shown in Table S5 . The results showed that the pIC 50 values of the newly designed inhibitor molecules were better than those of compound 33 and could be used as candidate compounds against the new coronavirus. Among them, compound 1-03 had the highest activity. The four compounds designed can be further studied by ADMET to predict whether they have a good inhibitory effect on SARS-CoV-2.

In order to understand the binding mode of cyclic sulfonamide derivatives and protease (PDB code:

7JYC, Resolution: 1.79 Å) and the antiviral mechanism of the designed compound, and to verify the results of the QSAR contour map, using SYBYL-X 2.0 software (Surflex-Dock) and discovery studio visualization tool 2017 evaluated their binding affinity to SARS-CoV-2 3CLpro. The docking scores of the compounds with the highest (33) activity and the lowest (2, 3, 7, 8, 25, 26, 27, 29) and the interaction patterns of the newly designed compounds with 7JYC were studied. The docking scoring results of the compounds are listed in Table S6 and the scoring functions were used to select the best ligands and predict their binding mode. The higher the scoring function value of Total-score, the better the affinity between the small molecule ligand extracted from the macromolecular protein and the receptor; the closer the absolute value of Crash is to zero, the smaller the degree of inappropriateness between the ligand and the receptor extracted from the macromolecular protein. Polar is the score of the polarity function, which can be divided into binding sites located on the surface (the higher the score, the better) and the interior of the molecule (the lower the score, the better) [40] . When the Total-score is greater than 5.0, the output posture is excellent. In this work, the Total score method was used to screen the best posture. Total-score, Crash score and Polar score are 6.01, -2.45 and 1.09, respectively.

In Fig.10(c) , compound 1-03 forms a hydrogen bond with GLU166 (NHO:1.827Å) and ARG188

(OHO:2.006Å); the hydrophobic channel was composed of Ala191, Leu167, Thr190 and His41.

Total-score, Crash score and Polar score are 5.65, -1.37 and 1.75, respectively. In Fig.10(d) , compound 1-04 forms a hydrogen bond with GLU166 (N-H-O:2.123 Å), and forms highly hydrophobic interactions with residues Ala191, Leu167, Phe185, Pro168, and Met165. Total-score, Crash score and Polar score are 5.11, -1.33 and 0.84, respectively. It was found that the designed new compound was in good agreement with the observed biological activity data, and had a higher activity and Total-score, indicating that the compound was successfully designed. Table S7 . The residual values of the QSAR model of cyclic sulfonamide derivatives are shown in Fig. 11 (a) and Fig. 11 

The pharmacokinetic/Pre ADMET toxicity predictor (Table S9 ) was used to predict the main pharmacokinetic parameters (absorption, distribution, metabolism, and excretion) and toxicological properties (Table S10) . Absorption is the process by which a drug enters the blood circulation from the site where the drug is used, and the drug can only exert its efficacy after being absorbed. Properties Table S9 , it was found that the new design compound showed good intestinal absorption at all of the above sites: greater than 91.00 % (allowable limit: 70 ~100 % abs), and the skin permeability was also within the acceptable range. In addition, the observed moderate permeability through Caco-2 cells in vitro was 84.78 to 88.37 nm/sc, and the detection value of in vitro MDCK cells was low.

The treatment strategy of most drugs is to transport the drugs to the blood through oral administration, subcutaneous injection and transdermal administration, and then distribute them to various tissues. Plasma proteins can adsorb a considerable proportion of drug molecules, and the binding of drugs to plasma proteins (PPB) in the body will directly affect the efficacy and toxicity of the drugs. Central nervous system (CNS) drugs must cross the blood-brain barrier (BBB) to penetrate into brain tissue. 4) . The metabolic stability of drugs in the body is one of the main factors that affect the pharmacokinetic properties, and unstable compounds often lead to poor pharmacokinetic and pharmacodynamic properties in the body. Cytochrome P450 (CYP450) is the main metabolic enzyme of drugs and other internal and exogenous substances, and its activity can be inhibited or induced by certain drugs. Oxidative metabolism by CYP450 enzymes is the most common way of metabolism. For CYP450-mediated moderate to low levels of metabolism, in vitro metabolic stability is well correlated with in vivo clearance. Calculate the ability of the tested compounds as inhibitors of drug metabolizing enzymes CYP2C19, CYP2C9, CYP2D6 and CYP3A4. In addition, the determination of glycoprotein (P-gp) inhibition rate can predict the excretion performance of the target compound. The tested compounds exhibited good inhibitory effect on CYP2C9 and CYP3A4, but had no inhibitory effect on CYP2C19 and CYP3A4. All the compounds exhibited an inhibitory effect on P-gp.

Toxicity is the degree of damage to the body or cells and organs of a substance, and it is one of the most important reasons for the failure of the late drug development. Predict the toxicological behavior of the test compound by measuring the AMES test, carcino-Mouse/Rate and hERG-inhibition (Table   S10 ). In the AMES test, half of the compounds showed non-mutagenic behavior. All compounds had negative carcinogenic effects in mice and rats, except for the low to medium risk cardiotoxic substances.

It is proved from the prediction of the ADMET performance of newly designed compounds that they may have good properties as lead compounds, and we can theoretically consider them to be the best SARS-CoV-2 inhibitors. It is worth noting that the synthetic feasibility of the designed compounds has been estimated to be around 4.17 ~ 4.5 (difficulty scale was 1 ~ 10), which proves that the difficulty of synthesis is moderate, and the test compounds had great potential to be successfully developed as a drug with low toxicological risk characteristics.

In this study, 2D (HQSAR) and 3D (Topomer CoMFA) methods were used to model 35 cyclic sulfonamide derivatives with anti-SARS-CoV-2 activity, and the ideal and reliable models were obtained. Topomer CoMFA contour maps and HQSAR fragment contribution maps were analyzed to identify the modification sites of the inhibitors, revealing important sites that may significantly affect (increase or decrease) molecular activity. By using molecule 33 as a template for fragment search, four new compounds were designed as potential inhibitors of SARS-CoV-2, and their pIC 50 values were predicted. Through molecular docking, the interaction between ligand and receptor protein was further explored, which verified the rationality of the results of the previous structure-activity relationship analysis and the deduced model. The docking results showed that the newly designed inhibitor molecule has a significant effect on the GLU166, GLN192, ALA194 and VAL186 sites of the protein(7JYC), and the formation of hydrogen bonds with ASN46 amino acid residues may be the main reason for its antiviral. ADMET prediction results have good pharmacokinetic properties, acceptable absorption, good metabolic conversion, low binding to hERG, no cytotoxicity, and can be used as a reliable SARS-CoV-2 inhibitor. In conclusion, we have used reliable computer-aided drug design methods to design more effective SARS-CoV-2 inhibitors. However, the accuracy of the prediction must be demonstrated experimentally. This study has implications for understanding the mechanism of inhibition of SARS-CoV-2 by cyclic sulfonamide derivatives, as well as for the design and synthesis of inhibitors.

Early transmission dynamics in Wuhan, China, of novel coronavirusinfected pneumonia

Druggable targets from coronaviruses for designing new antiviral drugs

Continuous on-body sensing for the COVID-19 pandemic: Gaps and opportunities

In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor

Exploring naphthyl derivatives as SARS-CoV papain-like protease (PLpro) inhibitors and its implications in COVID-19 drug discovery

Negative allosteric modulators of cannabinoid receptor 1: Ternary complexes including CB1, orthosteric CP55940 and allosteric ORG27569

A biaryl sulfonamide derivative as a novel inhibitor of filovirus infection

Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15

Molecular Hybrid Design, Synthesis and Biological Evaluation of N-Phenyl Sulfonamide Linked N-Acyl Hydrazone Derivatives Functioning as COX-2

Anti-Oxidant and Anti-Bacterial Agents

Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review

Design and synthesis of new N-(5-trifluoromethyl)-1H-1,2,4-triazol-3-yl benzenesulfonamides as possible antimalarial prototypes

New Synthesis and Analgesic and Diuretic Activity of Halo-Substituted 4-Hydroxy-1-Methyl-2,2-Dioxo-1H-2 lambda (6),1-Benzothiazine-3-Carboxanilides

Synthesis of novel 1,2-benzothiazine 1,1-dioxide-3-ethanone oxime N-aryl acetamide ether derivatives as potent anti-inflammatory agents and inhibitors of monocyte-to-macrophage transformation

Discovery of cyclicsulfonamide derivatives as 11β-hydroxysteroid dehydrogenase 1 inhibitors

QSAR, in silico docking and in vitro evaluation of chalcone derivatives as potential inhibitors for H1N1 virus neuraminidase

Insights into the Structural Requirements of Potent Brassinosteroids as Vegetable Growth Promoters Using Second-Internode Elongation as Biological Activity: CoMFA and CoMSIA Studies

Synthesis, antimalarial properties and 2D-QSAR studies of novel triazole-quinine conjugates

Discovery of cyclic sulfonamide derivatives as potent inhibitors of SARS-CoV-2

Contact company for pricing information

Bioactive conformational generation of small molecules: A comparative analysis between force-field and multiple empirical criteria based methods

Hologram QSAR study on the critical micelle concentration of Gemini surfactants

Comprehensive 3D-QSAR and binding mode of BACE-1 inhibitors using R-group search and molecular docking

Hologram quantitative structure-activity relationship and comparative molecular interaction field analysis of aminothiazole and thiazolesulfonamide as reversible LSD1 inhibitors

4D-QSAR studies of CB 2 cannabinoid receptor inverse agonists: a comparison to 3D-QSAR

Basic validation procedures for regression models in QSAR and QSPR studies: theory and application

Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection

The Better Predictive Model: High q2 for the Training Set or Low Root Mean Square Error of Prediction for the Test Set

Beware of q2

Combinatorial QSAR Modeling of P-Glycoprotein Substrates

Real external predictivity of QSAR models: how to evaluate it? Comparison of different validation criteria and proposal of using the concordance correlation coefficient

Synthesis, molecular docking studies, and in vitro evaluation of 1,3,5-triazine derivatives as promising antimicrobial agents

ZINC 15 -Ligand Discovery for Everyone

Isoform-Selective Enzyme Inhibitors by Exploring Pocket Size According to the Lock-and-Key Principle

Molecular Docking and Modeling to Cocrystallized Host Angiotensin-Converting Enzyme 2 (ACE2) and Viral Spike Protein

3D-QSAR and molecular docking analysis of biphenyl amide derivatives as p38α mitogen-activated protein kinase inhibitors

Structural investigation of tetrahydropteridin analogues as selective PLK1 inhibitors for treating cancer through combined QSAR techniques, molecular docking, and molecular dynamics simulations

Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of Coronavirus

silico ADME/T modelling for rational drug design

Synthesis, in vitro assays, molecular docking, theoretical ADMET prediction, and evaluation of 4-methoxy-phenylthiazole-2-amine derivatives as acetylcholinesterase inhibitors

Design of novel SHP2 inhibitors using Topomer CoMFA, HQSAR analysis, and molecular docking

The authors declare no competing financial interest